UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Warrant sought to arrest Medytox CEO for illegally making, selling Meditoxin
Prosecutors have requested a court to issue an arrest warrant for Medytox C...
by Jeong Sae-im
|
2020-03-25 14:09
라인
Will next-generation COVID-19 tests replace standard PCR checks?
Biotech companies are chasing new diagnostics to detect the new coronavirus...
by Jeong Sae-im
|
2020-03-25 11:40
라인
[Report from Daegu] Doctors guard prisons against COVID-19
DAEGU, South Korea – Prisons and detention centers are vulnerable to ...
by Jeong Sae-im
|
2020-03-18 14:56
라인
[Report from Daegu] Daegu Fatima Hospital delivers 6 babies from COVID-19 patients
DAEGU, South Korea – “As police have their duty, a hospital has its d...
by Jeong Sae-im
|
2020-03-13 15:48
라인
[Report from Daegu] Nurses fighting COVID-19 find no time to pause for breath
DAEGU, South Korea – Monday, at 506 West Ward in Kyungpook National U...
by Jeong Sae-im
|
2020-03-11 16:30
라인
[Report from Daegu] ‘Exhausted medical workers emerge as foremost issue in drawn-out struggle’
DAEGU, South Korea – “Workforce in second-tier hospitals couldn’t kee...
by Jeong Sae-im
|
2020-03-10 15:30
라인
GSK loses out to local drugmakers in quadrivalent flu vaccine sales
GSK’s sales of Fluarix Tetra, a vaccine against four different strains of i...
by Jeong Sae-im
|
2020-03-04 12:05
라인
Patients denied care at coronavirus-hit Eunpyeong St. Mary’s Hospital
A cancer patient, who used to receive chemotherapy at the Catholic Universi...
by Jeong Sae-im
|
2020-03-03 16:19
라인
Surging coronavirus tests cause reagent shortage
With the rapidly rising number of the new coronavirus tests, the nation is ...
by Jeong Sae-im
|
2020-03-02 14:36
라인
Korea approves 2 more COVID-19 detection kits for urgent use
The Korea Centers for Disease Control and Prevention (KCDC) has approved tw...
by Jeong Sae-im
|
2020-02-28 16:53
라인
HLB seeks new pipelines by taking over US biotech firm
HLB, a Kosdaq-listed firm, said it would seek to secure new pipelines other...
by Jeong Sae-im
|
2020-02-21 15:42
라인
Celltrion’s annual revenue surpassed ₩1 trillion in 2019
Celltrion, the nation’s leading biosimilar manufacturer, said its annual sa...
by Jeong Sae-im
|
2020-02-20 15:47
라인
Prescription of Celltrion’s Remsima SC started in Germany
Celltrion Healthcare, the distribution and marketing unit of Korea’s biosim...
by Jeong Sae-im
|
2020-02-18 16:05
라인
Drugmakers rush to roll out famotidine to replace ranitidine
Local pharmaceutical companies are quickly releasing medicines containing f...
by Jeong Sae-im
|
2020-02-18 15:07
라인
JW Pharmaceutical turns to loss on reduced sales of nutrients
JW Pharmaceutical said it reported operating loss in 2019, turning from an ...
by Jeong Sae-im
|
2020-02-14 12:03
라인
Coronavirus kills graduation ceremonies at medical, nursing schools
Weighed by growing fears of the spread of the novel coronavirus (COVID-19),...
by Jeong Sae-im
|
2020-02-12 11:43
라인
‘Worst has passed in new coronavirus outbreak’
The new coronavirus outbreak’s worst situation has passed because the growt...
by Jeong Sae-im
|
2020-02-10 16:08
라인
AstraZeneca Korea leaves umbrella trade union
AstraZeneca Korea’s branch of the Korea Democratic Pharmaceutical Union sai...
by Jeong Sae-im
|
2020-02-07 14:35
라인
Medytox, Daewoong in final battle over BTX strain ownership
The legal dispute between Medytox and Daewoong Pharmaceutical over the sour...
by Jeong Sae-im
|
2020-02-05 12:41
라인
Sillajen's loss more than doubles due to Pexa-Vec trial failure
Sillajen’s losses more than doubled last year as the company failed its pha...
by Jeong Sae-im
|
2020-02-03 16:08
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top